DETAILS OF RESEARCH

 

Synthetic Chemistry (Inorganic, Organometallic, Organic) for Functional Molecules

 

 

Applications:

·        Homogeneous Catalysis                (strategic ligand design, ferrocenes, redox-active catalysis)

·        Supramolecular Chemistry            (metal-alkynyl architecture, ‘molecular wires’)

·        Materials Science                             (electronic OLED/magnetic/optical materials)

·        Biomedical Imaging                         (PET labelled compounds, MRI contrast agents, quantum dots)

 

We have a diverse, multi-faceted research programme of both academic and industrial relevance featuring applied synthetic chemistry (crossing traditional inorganic and organic boundaries).  Elegant synthetic strategies have been developed, dovetailed with utilisation of the new compounds for applications within catalysis and materials science. Topics include:-

 

 

·        Metallocene chemistry, featuring new chiral and hemilabile, donor-substituted ferrocene ligands and redox-acitve transition metal pre-catalysts

Formation of novel hemilabile ligands with neutral and/or charged N/O, S/P, S/S and P/O substituents.  Interesting and unusual metal coordination chemistry observed and complexes tested for homogeneous catalytic processes i.e. olefin and lactide polymerisation, carbonylation, hydrogenation and Heck and Suzuki coupling reactions.

 

 

Redox-active catalysis - In a proof of concept study (see above – JACS, 2006), we have established for the first time that redox switches may be used to attenuate the activity of single-site polymerization catalysts. Thus, a titanium-based lactide polymerization initiator supported by a ferrocenyl-substituted salen ligand exhibits a substantially higher rate of propagation than its oxidized dicationic ferrocenium analogue. The reversibility of the redox event is demonstrated by treatment with chemical redox reagents.

 

(Key references:  J. Am. Chem. Soc, 2006, 128, 7410; Organometallics, 2006, 25, 1932; Dalton Trans., 2006, 3134; Chem. Soc. Rev., 2004, 33, 313).

 

 

·        Organometallic polymers, transition metal - alkynyl chemistry ('Molecular wires')

Mono-, oligo- and poly-nuclear metal-alkynyls synthesised and characterised for 2-D and 3-D supramolecular systems and formation of 'molecular wires'.  Interest in studying the electronic interactions within conjugated aromatic-alkynyl materials and gain understanding of the control of band-gap and conduction in these materials, properties probed by electrochemistry, absorption and emission spectroscopy and theoretical calculations.

 

 

(Key references:  Angew. Chem. Int. Ed., 2003, 42, 2586; Organometallics, 2006, 25, 2525; J. Organomet. Chem., 2006, 691, 1389).

                                                                       

 

 

·        Electroluminescent Materials - Lanthanide and Transition Metal Containing Complexes for Electro- and Photo-luminescent Materials (OLED devices)

Synthesis of metal-organic materials designed to possess particular properties (i.e. solubility, volatility, electroluminescence, phosphorescence) that are important in new commercially relevant devices.  Near-IR and triplet state emitting materials.

          In a key experiment (JACS, 2005), dramatic increases in the luminescent lifetime of the Er3+ ion in a molecular complex have been observed by chelating the rare-earth ion with a per-fluorinated imidodiphosphinate sensitizing ligand, ‘F-tpip’.  For solution, powder and evaporated thin films of Er(F-tpip)3 the average lifetimes of the 1530 nm emission band range between 150 – 220 μs, corresponding to a maximum 50-fold increase relative to the non-fluorinated analogue, Er(tpip)3.  These are the longest reported lifetimes for the Er3+ ion a simple organic chelate.  These remarkable improvements in luminescence efficiency and excited state lifetime represent a significant step forward in the design and fabrication of near-infrared (NIR) emitting molecular devices for communications, sensing and analytical detection.

 

 

 

(Key references:  J. Am. Chem. Soc., 2005, 127, 524; J. Am. Chem. Soc., 2004, 126, 5223).

 

 

·        Biomedical Imaging - Applications in PET Imaging and MRI/Optical Contrast Agents

We have recently embarked on projects sponsored by GlaxoSmithKline (GSK) to develop new chemistry and compounds featuring 11CO/11CO2 incorporation for PET imaging.  We are using transition metal-catalysed processes for the formation of 11C-labelled amides, esters and thioesters and form new transition metal macrocyclic CO/CO2-containing compounds, and apply the syntheses on a microfluidic scale via 'lab-on-a-chip' technology.  For the first time a microstructured device (see figure below) has been used to perform a gas-liquid carbonylation reaction - featuring the Pd-catalysed cross-coupling reaction of arylhalides with benzylamine and CO to rapidly form a range of secondary amides (Chem. Comm. 2006).

            

We are also interesting in Novel 11Carbon-Labelled Molecules for Non-Specific Binding for Positron Emission Tomography (PET). Current research is underway to understand the propensity of a PET-labelled drug to bind to a lipid membrane, and how this may interfere or enhance a molecule's ability to bind to and ultimately interact with the targeted enzyme or receptor. The ultimate objective is to design molecules that can target receptors and enzymes very specifically by providing insight into the way molecules cross biological membranes. This will greatly aid the development of better PET diagnostic imaging agents, the design of new drugs and improve the efficiency of the whole process of pharmaceutical drug development.  The figures below show 11C-PET scans, illustrating increasing non-specific binding of drug molecules in the brain.

  

 

Other related topics include new transition metal and lanthanide MRI contrast agents, featuring ligand design, and incorporation of specific metals such as Gd, Mn and Fe. 

 

And the synthesis of novel and biocompatible quantum dots. This project aims to diminish cytotoxicity of quantum dots with the use of biomaterials. These biomaterials will be either of natural origin or GRAS status (generally regarded as safe). Biocompatible polymers (and/or their modifications) will be assembled/conjugated on novel Quantum Dots to encapsulate them for minimal leakage.  The pictures on the right show cells labelled with quantum dots, under bright field and fluorescence.

 

 

 

(Key references:  Chem. Commun., 2006, 546; Chem. Soc. Rev., 2006, 35, 557).

 

 

Back to Intro Page

 

(last updated 17/11/06)